PerioTrap Pharmaceuticals
Molecular inhibitor against periodontitis

About PerioTrap Pharmaceuticals
Innovation in the dental sector
PerioTrap Pharmaceuticals GmbH specializes in the development of innovative oral care products. Its patented microbiome modulator is based on scientific findings and specifically blocks pathogenic bacteria. The unique mode of action strengthens and protects the natural barrier function of the oral flora, reduces the risk of infections and sustainably improves oral health.
Management
bmp Ventures Team
Founded
2019
Invested
2020
Stage
Seed
Industry
Life Sciences & eHealth
Status
Active